Mark Earl Hensley insider trades
Open-market stock purchases and sales by Mark Earl Hensley, Chief Operating Officer at Heron Therapeutics, Inc /de/, from SEC Form 4 filings since May 6, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 6, 2026 | HRTX Heron Therapeutics, Inc /de/ | Sold (not open market) | $4.4K |
| Aug 6, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Aug 6, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jul 31, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jul 31, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| May 6, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Apr 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jan 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jan 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
Companies traded
- HRTX Heron Therapeutics, Inc /de/: other filings, last Aug 6, 2026